ClinicalTrials.govpublic full text
A Study of Catequentinib Hydrochloride (AL3818) in Endometrial, LGSOC, STS or GBM Cancers
endometrial neoplasms, ovarian neoplasms, soft tissue sarcoma (sts), glioblastoma, interventional, phase1, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 825040
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.